The Approval of Teclistamab in Multiple Myeloma with Alfred Garfall, MD, UPENN

Name: The Approval of Teclistamab in Multiple Myeloma with Alfred Garfall, MD, UPENN
Start: 2022-11-14T13:30:00-05:00
End: 2022-11-14T14:30:00-05:00

The Approval of Teclistamab in Multiple Myeloma with Alfred Garfall, MD, UPENN

Podcast

Nov 14, 2022 / 01:30PM EST

Listen to Podcast

Event Description

CALL 347-637-2631 TO JOIN BY PHONE AND ASK QUESTIONS

Teclistamab is the first bispecific antibody to be FDA approved in mulitple myeloma. On this HealthTree Podcast for Multiple Myeloma episode, learn from Alfred Garfall, MD of the University of Pennsylvania about how it will be used in the clinic as an approved therapy.

Our discussion will include who qualifies for this new treatment, when patients should consider using it, if it can be combined with other myeloma therapies, if the therapy is continuous or can be stopped, common side effects to expect, how it is administered (in and outpatient) and how the caregiver needs to be involved.

We appreciate your donations to support the HealthTree Foundation Podcast.

DONATE

Schedule & Agenda

01:30 PM

Welcome

Jennifer Ahlstrom

Welcome, Announcements & Introduction

01:30 PM

Welcome

Jennifer Ahlstrom

Welcome, Announcements & Introduction

01:35 PM

Interview

Alfred Garfall, MD

A discussion with Alfred Garfall, MD about the recent approval of teclistamab, the first bispecific antibody in multiple myeloma.

01:35 PM

Interview

Alfred Garfall, MD

A discussion with Alfred Garfall, MD about the recent approval of teclistamab, the first bispecific antibody in multiple myeloma.

02:25 PM

Q&A

Alfred Garfall, MD

Audience is able to call in to the radio show. Call 347-637-2631 and press 1 on your keypad to ask Dr. Garfall questions about what was discussed during our interview today.

02:25 PM

Q&A

Alfred Garfall, MD

Audience is able to call in to the radio show. Call 347-637-2631 and press 1 on your keypad to ask Dr. Garfall questions about what was discussed during our interview today.

Speakers & Moderators

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Alfred Garfall, MD

Philadelphia, PA

Dr. Garfall is Director of the Autologous Hematopoietic Stem Cell Transplantation program and Assistant Professor of Medicine at the Hospital of the University of Pennsylvania.

Read Bio